05 Mar 2022
New Treatment Options For Acute Myeloid Leukemia
The traditional treatment for Acute Myeloid Leukemia is chemotherapy using cytarabine and anthracycline drugs. However, advances in the research of the pathophysiology of acute myeloid leukemia lead the way to recent developments in the different drugs used in chemotherapy. Since 2017, the Food and Drug Administration (FDA) of the United States has approved several drugs to treat AML. In this article, we will be exploring these recently approved drugs by the FDA in terms of the indication for their use and the Overall Survival (OS) that the specific drug achieved.
